M EngstromSummaryAffiliation: University of Oslo Country: Norway Publications
| Collaborators
|
Detail Information
Publications
Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesityT T Søvik
Departments of Gastrointestinal Surgery, Oslo University Hospital Aker, Oslo, Norway
Br J Surg 97:160-6. 2010..A randomized trial was conducted to evaluate perioperative (30-day) safety and 1-year results...
[Type 2 diabetes and metabolic syndrome before and after gastric bypass]Torgeir T Søvik
Senter for sykelig overvekt og Gastroenterologisk kirurgisk avdeling, Oslo universitetssykehus, Aker 0514 Oslo, Norway
Tidsskr Nor Laegeforen 130:1347-50. 2010..Overweight and obesity are associated with an increased risk of acquiring type 2 diabetes and metabolic syndrome. We have assessed the prevalence of these conditions before and after gastric bypass surgery for morbid obesity...
Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trialTorgeir T Søvik
Oslo University Hospital Aker, University of Oslo, Norway
Ann Intern Med 155:281-91. 2011..Gastric bypass and duodenal switch are currently performed bariatric surgical procedures. Uncontrolled studies suggest that duodenal switch induces greater weight loss than gastric bypass...
